Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation
- PMID: 29926900
- PMCID: PMC6220856
- DOI: 10.1002/bjs.10889
Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation
Abstract
Background: The prognostic equivalence between mastectomy and breast-conserving surgery (BCS) followed by radiotherapy was shown in pivotal trials conducted decades ago. Since then, detection and treatment of breast cancer have improved substantially and recent retrospective analyses point towards a survival benefit for less extensive breast surgery. Evidence for the association of such survival data with locoregional recurrence rates is largely lacking.
Methods: The Swedish Multicentre Cohort Study prospectively included clinically node-negative patients with breast cancer who had planned sentinel node biopsy between 2000 and 2004. Axillary lymph node dissection was undertaken only in patients with sentinel node metastases. For the present investigation, adjusted survival analyses were used to compare patients who underwent BCS and postoperative radiotherapy with those who received mastectomy without radiotherapy.
Results: Of 3518 patients in the Swedish Multicentre Cohort Study, 2767 were included in the present analysis; 2338 had BCS with postoperative radiotherapy and 429 had mastectomy without radiotherapy. Median follow-up was 156 months. BCS followed by whole-breast irradiation was superior to mastectomy without irradiation in terms of both overall survival (79·5 versus 64·3 per cent respectively at 13 years; P < 0·001) and breast cancer-specific survival (90·5 versus 84·0 per cent at 13 years; P < 0·001). The local recurrence rate did not differ between the two groups. The axillary recurrence-free survival rate at 13 years was significantly lower after mastectomy without irradiation (98·3 versus 96·2 per cent; P < 0·001).
Conclusion: The present data support the superiority of BCS with postoperative radiotherapy over mastectomy without radiotherapy. The axillary recurrence rate differed significantly, and could be one contributing factor in a complex explanatory model.
© 2018 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.
Figures



Similar articles
-
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16. Eur J Surg Oncol. 2017. PMID: 28139362 Clinical Trial.
-
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.Lancet Oncol. 2016 Aug;17(8):1158-1170. doi: 10.1016/S1470-2045(16)30067-5. Epub 2016 Jun 22. Lancet Oncol. 2016. PMID: 27344114
-
Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.Ann Surg Oncol. 2012 Nov;19(12):3762-70. doi: 10.1245/s10434-012-2386-3. Epub 2012 May 11. Ann Surg Oncol. 2012. PMID: 22576064
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.Eur J Surg Oncol. 2019 Aug;45(8):1317-1327. doi: 10.1016/j.ejso.2019.02.008. Epub 2019 Feb 10. Eur J Surg Oncol. 2019. PMID: 30795956
Cited by
-
Sentinel Lymph Node Biopsy in Early Breast Cancer Using Methylene Blue Dye Alone: a Safe, Simple, and Cost-Effective Procedure in Resource-Constrained Settings.Indian J Surg Oncol. 2021 Mar;12(1):210-217. doi: 10.1007/s13193-020-01273-6. Epub 2021 Jan 16. Indian J Surg Oncol. 2021. PMID: 33814855 Free PMC article.
-
Modeling and Synthesis of Breast Cancer Optical Property Signatures With Generative Models.IEEE Trans Med Imaging. 2021 Jun;40(6):1687-1701. doi: 10.1109/TMI.2021.3064464. Epub 2021 Jun 1. IEEE Trans Med Imaging. 2021. PMID: 33684035 Free PMC article.
-
Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer.BJS Open. 2021 Jan 8;5(1):zraa013. doi: 10.1093/bjsopen/zraa013. BJS Open. 2021. PMID: 33609387 Free PMC article.
-
Analysis of the Influencing Factors of Sentinel Lymph Node Metastasis in Breast Cancer.Evid Based Complement Alternat Med. 2022 Aug 9;2022:5775971. doi: 10.1155/2022/5775971. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9806363. doi: 10.1155/2023/9806363. PMID: 35983000 Free PMC article. Retracted.
-
A Hf(IV)-Coordinated NIR-II Fluorescence "Turn-On" Nanoprobe for Precise Imaging-Guided Surgery in Breast Cancer.Adv Sci (Weinh). 2025 Apr;12(14):e2413385. doi: 10.1002/advs.202413385. Epub 2025 Feb 14. Adv Sci (Weinh). 2025. PMID: 39950921 Free PMC article.
References
-
- Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L et al Eight‐year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822–828. - PubMed
-
- Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al Twenty‐year follow‐up of a randomized study comparing breast‐conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227–1232. - PubMed
-
- van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC et al 10 year survival after breast‐conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population‐based study. Lancet Oncol 2016; 17: 1158–1170. - PubMed
-
- Hofvind S, Holen Å, Aas T, Roman M, Sebuødegård S, Akslen LA. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol 2015; 41: 1417–1422. - PubMed
-
- Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on disease‐specific survival for early‐stage breast cancer. JAMA Surg 2014; 149: 267–274. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical